SARS-CoV-2: Virology, epidemiology, immunology and vaccine development

This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baay, Marc, Lina, Bruno, Fontanet, Arnaud, Marchant, Arnaud, Saville, Melanie, Sabot, Philippe, Duclos, Philippe, Vandeputte, Joris, Neels, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309765/
https://www.ncbi.nlm.nih.gov/pubmed/32600951
http://dx.doi.org/10.1016/j.biologicals.2020.06.005
Descripción
Sumario:This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

Ejemplares similares